Ongoing Prospective Multicenter Safety Study of Subcutaneous Cytoprotectant Amifostine for Head and Neck Carcinoma
Go back to Resources
Ongoing Prospective Multicenter Safety Study of Subcutaneous Cytoprotectant Amifostine for Head and Neck Carcinoma
Authors:
Secondary:
Location:
Go back to Resources